The “common soil hypothesis”: Evidence from population studies?

Thrombosis Research

Volumn 125, Issue , 2010, Pages S92-S95

  Donati, Maria Benedetta ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cardiovascular ischemic disease; Common soil; Hormone dependent tumors; Moli sani study

Indexed keywords

ANTICOAGULANT AGENT;

ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HUMAN; ISCHEMIA; METABOLISM; NEOPLASM;

ANIMALS; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; HUMANS; ISCHEMIA; NEOPLASMS, HORMONE-DEPENDENT;

EID: 77955482268     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70023-2     Document Type: Article

References (46)

1. Donati, MB, Cancer and cardiovascular disease: does a common soil exist?. Pathophysiol Haemost Thromb, 33(suppl 2), 2003, 1.
2. Donati, MB, Thrombosis and cancer: A personal view. Thromb Haemost 98 (2007), 126–128.
3. Iacoviello, L, Santimone, I, Latella, MC, de Gaetano, G, Donati, MB, Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes Nutr 3 (2008), 19–24.
4. Ross, JS, Stagliano, NE, Donovan, MJ, Breitbart, RE, Ginsburg, GS, Atherosclerosis: a cancer of the blood vessels?. Am J Clin Pathol 116:Suppl (2001), S97–S107.
5. Pikarsky, E, Porat, RM, Stein, I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004), 461–466.
6. Napoleone, E, Di Santo, A, Camera, M, Tremoli, E, Lorenzet, R, Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 86 (2000), 139–143.
7. Di Santo, A, Mezzetti, A, Napoleone, E, et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost 1 (2003), 1089–1095.
8. Donati, MB, Falanga, A, Lorenzet, R, Cancer and thrombosis: a two way interaction. Thrombosis. Fundamental and clinical aspects, 2003, Leuven University Press, 417–431.
9. Napoleone, E, Zurlo, F, Latella, MC, et al. Paclitaxel downregulates tissue factor in cancer and host tumor-associated cells. Eur J Cancer 45 (2009), 470–477.
10. Napoleone, E, Di Santo, A, Amore, C, et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?. J Thromb Haemost 5 (2007), 1462–1468.
11. Napoleone E, Cutrone A, Zurlo F, et al. Leptin enhances tissue factor synthesis in the human breast cancer cell line MCF7. [abstr. PP-MO-481]. XXII Congress ISTH, 2009, Boston.
12. Gaziano, JM, Fifth phase of the epidemiologic transition: the age of obesity and inactivity. JAMA 303 (2010), 275–276.
13. Jang, M, Cai, L, Udeani, GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997), 218–220.
14. Poggi, A, Polentarutti, N, Donati, MB, et al. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res 37 (1977), 272–277.
15. Bani, MR, Falanga, A, Alessio, MG, et al. Blood coagulation changes in nude mice bearing human colon carcinomas. Int J Cancer 50 (1992), 75–79.
16. Mussoni, L, Poggi, A, de Gaetano, G, et al. Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice. Br J Cancer 37 (1978), 126–129.
17. Poggi, A, Mussoni, L, Kornblihtt, L, et al. Warfarin enantiomers, anticoagulation, and experimental tumor metastasis. Lancet 1 (1978), 163–164.
18. Chmielewska, J, Poggi, A, Janik, P, et al. Effect of defibrination with batroxobin on growth and metastasis of JW sarcoma in mice. Eur J Cancer 16 (1980), 919–923.
19. Donati, MB, Poggi, A, Malignancy and haemostasis. Br J Haematol 44 (1980), 173–182.
20. Poggi, A, Donati, MB, Garattini, S, Fibrin and cancer cell growth: Problems in the evaluation of experimental models. Malignancy and the hemostatic system, 1981, Raven Press, New York, 89–101.
21. Poggi, A, Mussoni, L, Kornblihtt, L, et al. Warfarin enantiomers, anticoagulation, and experimental tumor metastasis. Lancet 1 (1978), 163–164.
22. Roncaglioni, MC, D'Alessandro, AP, Casali, B, et al. Gamma-glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. Haemostasis 16 (1986), 295–299.
23. Falanga, A, The effect of anticoagulant drugs on cancer. J Thromb Haemost 2 (2004), 1263–1265.
24. Lee, AY, Levine, MN, Baker, RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 (2003), 146–153.
25. Altinbas, M, Coskun, HS, Er, O, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2 (2004), 1266–1271.
26. Kakkar, AK, Levine, MN, Kadziola, Z, et al. Low molecular weight heparin therapy with dalteparin and survival in advanced cancer: the framing advanced malignancy outcome study (FAMOUS). J Clin Oncol 22 (2004), 1944–1948.
27. Klerk, CP, Smorenburg, SM, Otten, HM, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23 (2005), 2130–2135.
28. Lee, AY, Rickles, FR, Julian, JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 23 (2005), 2123–2129.
29. Maugeri, N, de Gaetano, G, Barbanti, M, et al. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparins. Haematologica 90 (2005), 815–821.
30. Maugeri, N, Di Fabio, G, Barbanti, M, et al. Parnaparin, a low molecular weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood. Thromb Haemost 97 (2007), 965–973.
31. Elwood, PC, Gallagher, AM, Duthie, GG, et al. Aspirin, salicylates and cancer. Lancet 373 (2009), 1301–1309.
32. Cuzik, J, Otto, F, Baron, JA, et al. Aspirin and non-stroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10 (2009), 501–507.
33. Holmes MD, Chen WY, Li L, et al. Aspirin intake and survival after breast cancer.2010 J Clin Oncol. published ahead of print February 17.
34. Tunstall-Pedoe, H, Kuulasma, K, Mahonen, M, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353 (1999), 1547–1557.
35. Trichopoulou, D, Lagiou, P, Dietary patterns and mortality. Brit J Nutr 85 (2001), 133–134.
36. La Vecchia, C, Chatenoud, L, Altieri, A, Tavani, A, Nutrition and Health: epidemiology of diet, cancer and cardiovascular disease in Italy. Nutr Metab Cardiovasc Dis 11:suppl 4 (2001), 10–15.
37. Trichopoulou, A, Costacou, T, Bamia, C, Trichopoulou, D, Adherence to a mediterranean diet and survival in a greek population. N Engl J Med 348 (2003), 2599–2608.
38. Sofi, F, Cesari, F, Abbate, R, et al. Adherence to Mediterranean diet and health status: meta-analysis. Brit Med J 337 (2008), 1334–1341.
39. Fung, TT, Hu, FB, McCullough, ML, et al. Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J Nutr 136 (2006), 466–472.
40. Reedy, J, Mitrou, PN, Krebs-Smith, SM, et al. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 168 (2008), 38–48.
41. Buckland, G, Agudo, A, Luján, L, et al. Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 91 (2010), 381–390.
42. Chan, AO, Jim, MH, Lam, KF, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 298 (2007), 1412–1419.
43. Inoue, M, Iwasaki, M, Otani, T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:17 (2006 Sep 25), 1871–1877.
44. Iacoviello, L, Bonanni, A, Costanzo, S, et al., on behalf of the Moli-sani Project Investigators. The Moli-sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, et al. Ital J Public Health 4 (2007), 110–118.
45. Centritto, F, Iacoviello, L, di Giuseppe, R, et al., Moli-sani Investigators. Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis 19 (2009), 697–706.
46. di Giuseppe, R, Di Castelnuovo, A, Centritto, F, et al. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. J Nutr 138 (2008), 1939–1945.